HOME >> MEDICINE >> NEWS
BIDMC investigator receives Novartis Award in Diabetes

BOSTON Endocrinologist Christos S. Mantzoros, MD, Director of the Human Nutrition Research Unit at Beth Israel Deaconess Medical Center (BIDMC), received the 2005 Novartis Award in Diabetes (Young Investigator) in a presentation held June 13, 2005, at the 65th Scientific Sessions of the American Diabetes Association in San Diego, California.

The annual Young Investigator award is sponsored by Novartis Pharmaceuticals to recognize a licensed physician under the age of 45 for innovative, patient-oriented research in the fields of physiology, pathophysiology or epidemiology of diabetes mellitus and its complications.

An Associate Professor of Medicine at Harvard Medical School, Mantzoros is a leader in the field of leptin research whose work has advanced the understanding of leptin as a hormonal mediator of the adaptation to starvation.

In clinical studies published in 2003, Mantzoros demonstrated that low leptin levels are responsible for key starvation-induced changes in neuroendocrine axes in humans, findings that have important implications for women with eating disorders and reproductive abnormalities. His subsequent research published in The New England Journal of Medicine provides valuable insights into the pathophysiology of hypothalamic amenorrhea, suggesting new therapeutic options for this prevalent condition.

"Chris's work is a perfect example of translational research," says BIDMC Chief Academic Officer Jeffrey S. Flier. "By applying the novel discoveries made in his lab to clinical studies of women suffering from amenorrhea, Chris has demonstrated that low leptin levels are indeed responsible for reproductive and neuroendocrine abnormalities. These findings are now leading to improved treatments for conditions affecting millions of women worldwide."

Mantzoros has additionally focused attention on the study of low-leptin states among HIV-positive patients, demonstrating that leptin replacement can ameliorate the
'"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
17-Jun-2005


Page: 1 2

Related medicine news :

1. BIDMCs Terry Strom, M.D., honored by American Society of Nephrology
2. BIDMCs Shapiro Simulation and Skills Center receives American College of Surgeons accreditation
3. BIDMCs Harold Dvorak, MD, honored by National Foundation for Cancer Research
4. BIDMCs Harvey Goldman, MD, receives distinguished pathologist award
5. BIDMC investigators receive award to study pathways responsible for obesity, type 2 diabetes
6. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
7. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators
8. Gladstone investigators identify a new protective action for the powerful anti-HIV factor, APOBEC3G
9. Telebriefing: NIH announces program for new scientific investigators
10. MUHC investigators search for the root of sexual pain in women
11. Indiana University Imaging Center receives $6M grant for kidney research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: BIDMC investigator receives Novartis Award Diabetes

(Date:5/22/2013)... 2013, Paris, France: Results from a large ... question whether bivalirudin is superior to heparin ... similar 30-day mortality in patients with non-ST ... percutaneous coronary intervention (PCI)., European and US ... an alternative to unfractionated heparin plus GP ...
(Date:5/22/2013)... In the past decade, more than 500,000 ... with donated uniforms, shoes, balls and other equipment, thanks ... with manufacturers to provide youth with sporting goods. Now, ... in sports and fitness equipment over 10 years, as ... physical activity. , An inaugural donation of 500 ...
(Date:5/22/2013)... Kincardine, Ontario, CA (PRWEB) May 22, 2013 ... Meltdown Challenge, the fitness franchise Fit Body ... its 2nd Annual 1,000 lb. Meltdown Challenge starting on ... located at Davidson Centre 601 Durham Street, Kincardine, Ontario.     ... goal is to inspire and motivate local community residents ...
(Date:5/22/2013)... May 22, 2013 AvePoint ... solutions for social enterprise collaboration platforms, today announced ... firm based in Chicago, Ill. The agreement will ... and provide best-in-class solutions for SharePoint deployments, enabling ... , AvePoint’s DocAve Software Platform and ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Poor adherence ... in not only medical complications and death (some 125,000 ... drug non-adherence), but increased health-care costs. It’s been estimated ... admissions are related to poor medication adherence — a ... billion annually. , Indeed, so dire is the degree ...
Breaking Medicine News(10 mins):Health News:Registry questions superiority of bivalirudin over heparin 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 3Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2
(Date:5/21/2013)... Massachusetts , 21. Mai 2013 /PRNewswire/ ... („OSI"), die die Firmen OMNIlife science® Inc., Enztec ... zählt, hat zwei neue, erfahrene Mitglieder in ... , eine erfahrene Führungspersönlichkeit aus der ... David Johnson , anerkannter ...
(Date:5/21/2013)... May 21, 2013  LCA-Vision Inc. (NASDAQ: LCAV ... the Lasik Plus ® brand, announces that all nominees to ... at today,s annual meeting of stockholders.  These Directors are: ... President of Bahl & Gaynor Investment Counsel , ... , Edgar F. Heizer III , ...
(Date:5/21/2013)... 21, 2013  Decision Resources, one of ... for pharmaceutical and healthcare issues, finds that ... key efficacy endpoints, including overall survival and ... influence over surveyed U.S. and European oncologists, ... HER2-negative breast cancer. The two novel emerging ...
Breaking Medicine Technology:Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 2Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 3LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2
Cached News: